• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of prosciprotein sciencecshl presssubscriptionsetoc alertsthe protein societyjournal home
Protein Sci. Mar 1998; 7(3): 556–563.
PMCID: PMC2143946

Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination.

Abstract

Carbonic anhydrase IV (CAIV) is a membrane-associated enzyme anchored to plasma membrane surfaces by a phosphatidylinositol glycan linkage. We have determined the 2.8-angstroms resolution crystal structure of a truncated, soluble form of recombinant murine CAIV. We have also determined the structure of its complex with a drug used for glaucoma therapy, the sulfonamide inhibitor brinzolamide (Azopt). The overall structure of murine CAIV is generally similar to that of human CAIV; however, some local structural differences are found in the active site resulting from amino acid sequence differences in the "130's segment" and the residue-63 loop (these may affect the nearby catalytic proton shuttle, His-64). Similar to human CAIV, the C-terminus of murine CAIV is surrounded by a substantial electropositive surface potential that may stabilize the interaction with the phospholipid membrane. Binding interactions observed for brinzolamide rationalize the generally weaker affinity of inhibitors used in glaucoma therapy toward CAIV compared with CAII.

Full Text

The Full Text of this article is available as a PDF (7.9M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Baldwin JJ, Ponticello GS, Anderson PS, Christy ME, Murcko MA, Randall WC, Schwam H, Sugrue MF, Springer JP, Gautheron P, et al. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. J Med Chem. 1989 Dec;32(12):2510–2513. [PubMed]
  • Ben-Tal N, Honig B, Peitzsch RM, Denisov G, McLaughlin S. Binding of small basic peptides to membranes containing acidic lipids: theoretical models and experimental results. Biophys J. 1996 Aug;71(2):561–575. [PMC free article] [PubMed]
  • Boriack-Sjodin PA, Heck RW, Laipis PJ, Silverman DN, Christianson DW. Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-A resolution: implications for catalytic proton transfer and inhibitor design. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10949–10953. [PMC free article] [PubMed]
  • Brechue WF, Kinne-Saffran E, Kinne RK, Maren TH. Localization and activity of renal carbonic anhydrase (CA) in CA-II deficient mice. Biochim Biophys Acta. 1991 Jul 22;1066(2):201–207. [PubMed]
  • Brown D, Zhu XL, Sly WS. Localization of membrane-associated carbonic anhydrase type IV in kidney epithelial cells. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7457–7461. [PMC free article] [PubMed]
  • Brünger AT, Kuriyan J, Karplus M. Crystallographic R factor refinement by molecular dynamics. Science. 1987 Jan 23;235(4787):458–460. [PubMed]
  • Effros RM, Mason G, Silverman P. Asymmetric distribution of carbonic anhydrase in the alveolar-capillary barrier. J Appl Physiol Respir Environ Exerc Physiol. 1981 Jul;51(1):190–193. [PubMed]
  • Eriksson AE, Kylsten PM, Jones TA, Liljas A. Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH. Proteins. 1988;4(4):283–293. [PubMed]
  • Eriksson AE, Liljas A. Refined structure of bovine carbonic anhydrase III at 2.0 A resolution. Proteins. 1993 May;16(1):29–42. [PubMed]
  • Greer J, Erickson JW, Baldwin JJ, Varney MD. Application of the three-dimensional structures of protein target molecules in structure-based drug design. J Med Chem. 1994 Apr 15;37(8):1035–1054. [PubMed]
  • Hageman GS, Zhu XL, Waheed A, Sly WS. Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc Natl Acad Sci U S A. 1991 Apr 1;88(7):2716–2720. [PMC free article] [PubMed]
  • Håkansson K, Carlsson M, Svensson LA, Liljas A. Structure of native and apo carbonic anhydrase II and structure of some of its anion-ligand complexes. J Mol Biol. 1992 Oct 20;227(4):1192–1204. [PubMed]
  • Hurt JD, Tu C, Laipis PJ, Silverman DN. Catalytic properties of murine carbonic anhydrase IV. J Biol Chem. 1997 May 23;272(21):13512–13518. [PubMed]
  • Liljas A, Kannan KK, Bergstén PC, Waara I, Fridborg K, Strandberg B, Carlbom U, Järup L, Lövgren S, Petef M. Crystal structure of human carbonic anhydrase C. Nat New Biol. 1972 Feb 2;235(57):131–137. [PubMed]
  • Lucci MS, Tinker JP, Weiner IM, DuBose TD., Jr Function of proximal tubule carbonic anhydrase defined by selective inhibition. Am J Physiol. 1983 Oct;245(4):F443–F449. [PubMed]
  • Matthews BW. Solvent content of protein crystals. J Mol Biol. 1968 Apr 28;33(2):491–497. [PubMed]
  • Okuyama T, Sato S, Zhu XL, Waheed A, Sly WS. Human carbonic anhydrase IV: cDNA cloning, sequence comparison, and expression in COS cell membranes. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1315–1319. [PMC free article] [PubMed]
  • Prugh JD, Hartman GD, Mallorga PJ, McKeever BM, Michelson SR, Murcko MA, Schwam H, Smith RL, Sondey JM, Springer JP, et al. New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides. J Med Chem. 1991 Jun;34(6):1805–1818. [PubMed]
  • Quigley HA. Open-angle glaucoma. N Engl J Med. 1993 Apr 15;328(15):1097–1106. [PubMed]
  • Sly WS, Hu PY. Human carbonic anhydrases and carbonic anhydrase deficiencies. Annu Rev Biochem. 1995;64:375–401. [PubMed]
  • Smith GM, Alexander RS, Christianson DW, McKeever BM, Ponticello GS, Springer JP, Randall WC, Baldwin JJ, Habecker CN. Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors. Protein Sci. 1994 Jan;3(1):118–125. [PMC free article] [PubMed]
  • Stams T, Nair SK, Okuyama T, Waheed A, Sly WS, Christianson DW. Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-A resolution. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13589–13594. [PMC free article] [PubMed]
  • Tamai S, Waheed A, Cody LB, Sly WS. Gly-63-->Gln substitution adjacent to His-64 in rodent carbonic anhydrase IVs largely explains their reduced activity. Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13647–13652. [PMC free article] [PubMed]
  • Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol. 1994 Jan;112(1):69–73. [PubMed]
  • Vidgren J, Liljas A, Walker NP. Refined structure of the acetazolamide complex of human carbonic anhydrase II at 1.9 A. Int J Biol Macromol. 1990 Dec;12(6):342–344. [PubMed]
  • Waheed A, Okuyama T, Heyduk T, Sly WS. Carbonic anhydrase IV: purification of a secretory form of the recombinant human enzyme and identification of the positions and importance of its disulfide bonds. Arch Biochem Biophys. 1996 Sep 15;333(2):432–438. [PubMed]
  • Whitney PL, Briggle TV. Membrane-associated carbonic anhydrase purified from bovine lung. J Biol Chem. 1982 Oct 25;257(20):12056–12059. [PubMed]
  • Zhu XL, Sly WS. Carbonic anhydrase IV from human lung. Purification, characterization, and comparison with membrane carbonic anhydrase from human kidney. J Biol Chem. 1990 May 25;265(15):8795–8801. [PubMed]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...